Document is current
Any future updates will be listed below
-
Authors
Henriques, Ana https://orcid.org/0000-0002-2421-4308
Salvany-Celades, Maria
Nieto, Paula https://orcid.org/0000-0002-0083-9901
Palomo-Ponce, Sergio https://orcid.org/0000-0002-3371-6457
Sevillano, Marta
Hernando-Momblona, Xavier https://orcid.org/0000-0003-0755-333X
Middendorp-Guerra, Emily
Llanses Martinez, Montserrat https://orcid.org/0000-0002-5600-9181
Haak, Elisabeth Marjolein https://orcid.org/0009-0008-1489-6721
Nieto, Juan https://orcid.org/0000-0002-3400-1488
Caratú, Ginevra
Marchese, Domenica
Ruiz Gil, Max
Tosi, Sebastien
Suckert, Theresa https://orcid.org/0000-0003-0380-9772
Badia-Ramentol, Jordi
Caballé-Mestres, Adrià
Sanchez-Zarzalejo, Carolina https://orcid.org/0000-0002-7059-5658
Mateo, Lidia https://orcid.org/0000-0002-9076-4025
Tauriello, Daniele V. F. https://orcid.org/0000-0003-1522-3496
Riera, Antoni https://orcid.org/0000-0001-7142-7675
Sancho, Elena https://orcid.org/0000-0002-8182-513X
Attolini, Camille Stephan-Otto https://orcid.org/0000-0001-8045-320X
Prados, Alejandro https://orcid.org/0000-0002-8610-7559
Heyn, Holger https://orcid.org/0000-0002-3276-1889
Batlle, Eduard https://orcid.org/0000-0003-2422-0326
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 19 September 2025
First Online: 7 November 2025
Competing interests
: H.H. is a cofounder and the chief scientific officer of Omniscope; a scientific advisory board member at NanoString, Bruker and Mirxes; and a consultant for Moderna; and has received honoraria from Genentech. E.B. and D.V.F.T. hold a patent on the synthesis and use of a TGFBRI small-molecule inhibitor. The laboratory of E.B. has received research funding from Merus, Incyte and Revolution Medicines. E.B. has received honoraria for consulting from Genentech. The other authors declare no competing financial interests.
